文献速递免疫规划

优化成人免疫接种的针头长度与接种部位选择

Optimizing needle length and site choice for adult immunization.
PubMed 文献 · Vaccine · 2023-06-24

本研究通过120例肩部CT扫描,按美国CDC体重和性别分组评估三角肌肌内注射的理想针头长度和部位。结果显示,肩峰后外侧角远端4 cm处为最佳注射点,比CDC推荐更靠后靠下;体重<118 kg者应慎用1.5英寸针头,因过度穿透预测率高。

要点

  • 肩峰后外侧角远端4 cm处是成人三角肌肌内注射的理想部位,比CDC推荐更靠后靠下。
  • 体重<60 kg者,0.625英寸针头在中外侧轨迹远端4 cm处成功率达100%。
  • 体重60-70 kg及女性70-90 kg/男性70-118 kg者,1英寸针头在后外侧轨迹远端4 cm处成功率>80%,过度穿透<15%。

核心结论

  • 成人三角肌肌内注射的理想部位为肩峰后外侧角远端4 cm处,该部位比美国CDC推荐更靠后靠下,可最大化肌内接种成功率、减少过度穿透并避免腋神经损伤。
  • 体重<118 kg者慎用1.5英寸针头,因过度穿透预测率高。

研究设计与样本

  • 研究评估了120例肩部CT扫描,按美国CDC推荐的体重和性别分组:第1组<60 kg,第2组60-70 kg,第3组女性70-90 kg和男性70-118 kg,第4组女性>90 kg和男性>118 kg。
  • 在肩峰后外侧角远端2、4、6 cm处,对5种独特轨迹测量皮肤至三角肌筋膜距离和三角肌宽度,并模拟0.625英寸、1.0英寸和1.5英寸针头在各部位的接种位置。

主要发现

  • 第1组:0.625英寸针头在中外侧轨迹远端4 cm处成功接种率为100%。
  • 第2-3组:1英寸针头在后外侧轨迹远端4 cm处成功肌内接种率>80%,过度穿透率<15%,同时最小化腋神经风险。
  • 第4组:1.5英寸针头采用相同策略成功率最高(96%),过度穿透率最低(4%)。
  • 所有针头长度下,过度穿透与更靠前和更靠上的注射部位相关(两者P<0.001)。

关键数值与推荐

  • 第1组(<60 kg):0.625英寸针头,中外侧轨迹,肩峰后外侧角远端4 cm,成功接种率100%。
  • 第2-3组(60-70 kg及女性70-90 kg/男性70-118 kg):1英寸针头,后外侧轨迹,远端4 cm,成功率>80%,过度穿透率<15%。
  • 第4组(女性>90 kg/男性>118 kg):1.5英寸针头,后外侧轨迹,远端4 cm,成功率96%,过度穿透率4%。

临床怎么用

  • 作者认为,成人三角肌肌内注射的理想部位为肩峰后外侧角远端4 cm处,比CDC推荐更靠后靠下。
  • 作者提醒,体重<118 kg者慎用1.5英寸针头,因过度穿透预测率高。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Current recommendations for needle length and vaccination site for intramuscular deltoid vaccinations are backed by minimal data. AIM: To determine the ideal needle length and vaccination site for intramuscular deltoid vaccine administration. METHODS: 120 shoulder CT scans were evaluated and grouped by patient weight and sex as recommended by the United States CDC: Group 1, <60 kg, Group 2, 60-70 kg, Group 3, females 70-90 kg and males 70-118 kg, and Group 4, females > 90 kg and males > 118 kg. For each group, distance from skin to deltoid fascia and deltoid muscle width were measured at 2, 4, and 6 cm distal to the posterolateral corner of the acromion for 5 unique trajectories. Needle lengths of 0.625″, 1.0″, and 1.5″ were simulated at each site to determine inoculation location relative to the deltoid. RESULTS: For Group 1, a 0.625″ needle in the mid-lateral (ML) trajectory 4 cm distal to the posterolateral corner provided a perfect rate of successful inoculations (100 %). For Groups 2-3, a 1″ needle in the posterolateral (PL) trajectory 4 cm distal provided high rates (>80 %) of successful intramuscular inoculations with low rates of overpenetration (<15 %) while minimizing risk to the axillary nerve. For Group 4, a 1.5″ needle using the same strategy provided the highest rate of successful inoculations (96 %) and minimal overpenetration (4 %). Overpenetration was associated with more anterior and superior injection sites (P < 0.001 for both) for all needle lengths. CONCLUSIONS: The overall ideal injection site to maximize successful intramuscular vaccine administration, minimize overpenetration, and avoid axillary nerve injury is 4 cm distal to and in line with the posterolateral corner of the acromion, a site more posterior and inferior than current CDC recommendations. We caution against use of a 1.5″ needle for patients < 118 kg due to high predicted rates of overpenetration.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Mardourian M, Hao KA, Wiggins W, et al. Optimizing needle length and site choice for adult immunization. Vaccine. 2023. PMID: 37365058. doi:10.1016/j.vaccine.2023.06.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。